Marc Rosen

607 total citations
8 papers, 444 citations indexed

About

Marc Rosen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Organic Chemistry. According to data from OpenAlex, Marc Rosen has authored 8 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Marc Rosen's work include Prostate Cancer Treatment and Research (3 papers), Peptidase Inhibition and Analysis (2 papers) and Ubiquitin and proteasome pathways (2 papers). Marc Rosen is often cited by papers focused on Prostate Cancer Treatment and Research (3 papers), Peptidase Inhibition and Analysis (2 papers) and Ubiquitin and proteasome pathways (2 papers). Marc Rosen collaborates with scholars based in United States, Netherlands and Australia. Marc Rosen's co-authors include Dachelle Johnson, George L. Drusano, Harold C. Standiford, Samuel R. Denmeade, Oladapo Bakare, Bernard Kwabi‐Addo, Brian W. Simons, Susan L. Dalrymple, Lei Zheng and W. Nathaniel Brennen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Marc Rosen

8 papers receiving 430 citations

Peers

Countries citing papers authored by Marc Rosen

Since Specialization

Citations

This map shows the geographic impact of Marc Rosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Rosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Rosen more than expected).

Fields of papers citing papers by Marc Rosen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Rosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Rosen. The network helps show where Marc Rosen may publish in the future.

Co-authorship network of co-authors of Marc Rosen

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Rosen. A scholar is included among the top collaborators of Marc Rosen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Rosen. Marc Rosen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	A hemi‐spleen injection model of liver metastasis for prostate cancer 2020 ·The Prostate ·Brian W. Simons, Susan L. Dalrymple, Marc Rosen, Lei Zheng, W. Nathaniel Brennen	10
2	Abstract 517: Supraphysiological androgens activate innate immune signaling in prostate cancer 2019 ·Immunology ·Janet Mendonca, Olutosin Owoyemi, Marc Rosen, Michael Carducci, Mark C. Markowski, Emmanuel S. Antonarakis, Drew M. Pardoll, Samuel R. Denmeade, Sushant K. Kachhap	1
3	Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivatives 2017 ·Bioorganic & Medicinal Chemistry ·(unknown), Marc Rosen, Oladapo Bakare, Samuel R. Denmeade	21
4	Combining the pan‐aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer 2014 ·Cancer Medicine ·Channing J. Paller, Michel D. Wissing, Janet Mendonca, Anup Sharma, Eugene S. Kim, (unknown), Madeleine S.Q. Kortenhorst, (unknown), Marc Rosen, Faraz Shaikh, Marianna Zahurak, Michelle A. Rudek, Hans J. Hammers, Charles M. Rudin, Michael A. Carducci, Sushant K. Kachhap	22
5	Design, Synthesis, and Evaluation of pH-Dependent Hydrolyzable Emetine Analogues as Treatment for Prostate Cancer 2012 ·Journal of Medicinal Chemistry ·(unknown), Marc Rosen, Samuel R. Denmeade, Bernard Kwabi‐Addo, Oladapo Bakare	32
6	Phase I, pharmacokinetic, and pharmacodynamic evaluation of BNC105P, a novel anticancer agent that is both a vascular disrupting agent (VDA) and an inhibitor of cancer cell proliferation 2009 ·Journal of Clinical Oncology ·Jayesh Desai, Stephen Q. Wong, Geoffrey Chong, David C. Bibby, Annabell F. Leske, Gabriel Kremmidiotis, Marc Rosen, Danny Rischin	4
7	Prostate-Specific Membrane Antigen (PSMA) targeted prodrug “smartbombs” as therapy for prostate cancer 2006 ·Cancer Research ·(unknown), Pratap Singh, Marc Rosen, Craig A. Dionne, S. Brøgger Christensen, John T. Isaacs, Samuel R. Denmeade	1
8	Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis 1993 ·Antimicrobial Agents and Chemotherapy ·George L. Drusano, Dachelle Johnson, Marc Rosen, Harold C. Standiford	353

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact